{"id":"W2155567491","doi":"10.1016/j.jacc.2009.04.007","title":"End Points and Clinical Trial Design in Pulmonary Arterial Hypertension","year":2009,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"Pfizer","keywords":"Medicine; Clinical trial; Pulmonary hypertension; End point; Intensive care medicine; Clinical endpoint; Modalities; Clinical study design; Randomized controlled trial; Placebo; Quality of life (healthcare); Cardiology; Internal medicine; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01825822,0.001010078,0.00886496,0.001354514,0.0002304533,0.001731457,0.001691299,0.00202519,0.005563909],"category_scores_gemma":[0.0361313,0.0004879957,0.00338549,0.001601872,0.0006663126,0.001114006,0.0007259847,0.002853301,0.0004271782],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000862311,"about_ca_system_score_gemma":0.001409463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004042375,"about_ca_topic_score_gemma":0.001224422,"domain_scores_codex":[0.9892606,0.007667492,0.001539634,0.0005584497,0.0008159834,0.0001578495],"domain_scores_gemma":[0.9483066,0.04704594,0.003034848,0.0004145749,0.0008702136,0.0003278092],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01548527,0.0003398828,0.00157171,0.2000685,0.01661105,0.0001472178,0.0001020573,0.001173999,0.0004949408,0.00434477,0.01643493,0.7432257],"study_design_scores_gemma":[0.1134541,0.01631087,0.03260296,0.2519421,0.1881266,0.001982438,0.0003951249,0.007481282,0.002083125,0.04967891,0.3355258,0.0004166535],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008579908,0.9968681,0.0006578644,0.000542145,0.0003894604,0.00009552852,0.00009186362,0.00001120229,0.0004858541],"genre_scores_gemma":[0.03739033,0.9521967,0.004231918,0.002948874,0.001653944,0.0007419665,0.0002435875,0.00001549184,0.0005771416],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01825822,"threshold_uncertainty_score":0.09655988,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1096870490308459,"score_gpt":0.3924779982567499,"score_spread":0.282790949225904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}